The AIDS epidemic in Italy has been characterized by a high percentage of individuals infected through injecting drug use (nearly 70%), of women (more than 20%), and of individuals infected through heterosexual contact (more than 10%). 1 The annual number of reported AIDS cases increased steadily until 1995, peaking at 5388 cases, and then slightly decreased in 1996 (4642 cases). Some important changes in the AIDS epidemic in Italy have occurred over time. 
median number of CD4 + cells at AIDS diagnosis steadily declined from 68 cells/mm 3 in 1990 to 46 cells/mm 3 in 1996. 1 Trends in the frequency of AIDS-defining diseases are influenced by several factors, including the prevalence of causal infectious agents in the population, or in specific segments of it, the different level of immunosuppression at which each opportunistic agent emerges, and the different incubation periods of AIDS-defining diseases. [2] [3] [4] The underlying incidence rates of new HIV infections, 5 changes in the case definition for AIDS, [6] [7] [8] [9] variations in diagnostic standards, and the extent of the adoption of therapeutic interventions for preventing or treating specific diseases can also play a role. 10 Many studies on the trends of AIDS-defining diseases based on AIDS surveillance data have focused on specific diseases, [11] [12] [13] while fewer, 14, 15 in addition to follow-up 16 and mortality 17 investigations of HIV-infected individuals, have evaluated the full spectrum of AIDS-defining diseases.
In this paper we report the results of an original approach used to investigate temporal patterns for all AIDS-defining diseases among Italian cases diagnosed up to December 1996, and reported to the National AIDS Registry up to March 1997.
Methods
The study included all AIDS-defining diseases reported among Italian adult residents (i.e. aged у13 years) diagnosed with AIDS from the beginning of the epidemic in 1982 to December 1996 and notified to the Italian AIDS Registry up to March 1997. Detailed information on the AIDS Registry has been provided elsewhere. 18 Briefly, when any AIDS-defining disease is diagnosed in an HIV-positive individual, according to the US Centres for Disease Control and Prevention case definition criteria, [6] [7] [8] and the European 1993 definition, 9 it is compulsory to report the case on a standard form to the National AIDS Registry. As concerns reporting delay, it is estimated that after one year of AIDS diagnosis, nearly 95% of cases are notified to the national surveillance system. Underreporting has been evaluated to be less than 10% of the total number of AIDS cases. 19 Several types of information are collected at AIDS diagnosis, including demographic indicators (e.g. age, gender, place of residence), HIV-exposure category, type and date of diagnosis of AIDS-defining diseases (up to six diseases can be reported) that occurred within 2 months of the date of onset of the first disease, and, since 1990, CD4 + cell count at AIDS diagnosis. When more than one risk factor for HIV infection is reported, the case is assigned to one HIV exposure category according to the following hierarchy: IDU, homosexual and bisexual men, recipients of blood or of blood derivatives, heterosexuals, and other/unknown. 18 The 26 AIDS-defining diseases included in the European AIDS definition of an adult case were grouped according to an aetiological criterion, or by type of cancer, into the following 12 groups (Table 1) : (1) The total number of diagnoses of AIDS-defining diseases, and the relative frequency of the 12 categories mentioned above, were evaluated according to age, gender, HIV-exposure category, year of diagnosis, and CD4 + cell count. Associations of each diagnostic group with the previous variables were evaluated using the χ 2 test: to take multiple testing into account, statistically significant associations were considered for those for which P-values were Ͻ0.001. A multivariate polychotomous non-ordinal logistic model 20 was used to estimate the proportions of AIDS-diagnostic category for four time periods, chosen according to number of diagnoses: 1989 or earlier, 1990-1992, 1993-1994, and 1995-1996 . Invasive cervical carcinoma was excluded from this analysis because of the very low frequency (86 diagnoses were reported), and because it has been included among the AIDS-defining diseases only since 1993. The relative frequency of each of the 11 diagnostic categories was simultaneously adjusted for the remaining categories, and for age, gender, and HIV-exposure category.
To better assess whether temporal trends were influenced by changes in the AIDS case-definition, we performed a further analysis restricted to the conditions included in the pre-1987 case definition. 6 Moreover, to investigate whether the observed time trends were influenced by the level of immunosuppression, we estimated the proportions of the AIDS-diagnostic categories separately for three groups of CD4 + cell counts at AIDS diagnosis (у100; 50-99; and р49 cells/mm 3 ) among cases diagnosed beginning in 1990 (i.e. the year in which the CD4 + cell counts at AIDS diagnosis began to be routinely reported to the AIDS Registry). Descriptive analyses were conducted using the SAS software; 21 the STATA software was used to fit the polychotomous non-ordinal logistic models. 22 
Results
Between 1982 and 1996, a total of 36 638 adults (28 873 males [78.8%] and 7765 females [21.2%]) were diagnosed with AIDS and reported to the AIDS Registry as of March 1997. A total of 41 772 AIDS-defining diseases were reported (11.4% of cases had two concurrent diseases, and 1.5% had three to five concurrent diseases). Table 1 shows the frequency of the 12 groups of AIDSdefining diseases. Mycoses represented the most commonly diagnosed category (27.3% of total; oesophageal candidiasis represented 81.3% of mycoses diagnosed), followed by PCP (21.4%). Each of the remaining groups accounted for less than 9% of reported diseases, ranging from 8.9% for viral infections to 2.1% for bacterial infections and 2.1% for protozoal infections. Cancers accounted for 7.9% of the AIDS-defining diseases: KS was the most common tumour (4.9%), followed by NHL (3.0%). Of the total diseases reported among women, ICC accounted for 0.2%.
The frequency of AIDS-defining diseases was similar in the two sexes, though viral infections were more frequently diagnosed among women (11.1% versus 8.0%, P Ͻ 0.0001) and KS among men (5.8% versus 1.8%, P Ͻ 0.0001) ( Table 2) . Some statistically significant variations (P Ͻ 0.001) by age and HIV-exposure category were also observed. The frequencies of mycoses and of brain toxoplasmosis significantly decreased with age, whereas those for viral infections, HIV encephalopathy, wasting syndrome, and KS tended to increase. IDU were more frequently diagnosed with mycoses and less frequently with viral infections or NHL; homosexual/bisexual men were more frequently diagnosed with KS and less frequently with HIV encephalopathy or wasting syndrome than the remaining categories ( Table 2 ).
The observed temporal changes in the frequency of AIDSdefining diseases are shown in Figure 1 . A steady decline was observed with respect to mycoses (from 45.0% in 1986 to 26.7% in 1996) and KS (from 11.0% to 4.8%). Up to 1990, PCP increased but declined thereafter (20.1% in 1996) , whereas the frequency of viral infections was at its highest in 1996. Divergent time trends were observed for brain toxoplasmosis (its frequency increased up to 1992 and decreased thereafter), mycobacterioses, HIV encephalopathy and wasting syndrome. The frequency of NHL peaked in 1987 (6.6%) and declined thereafter (3.6% in 1996) .
The aforementioned temporal patterns were re-assessed by means of multinomial analysis. Table 3 shows the estimated proportions for each of the 11 categories (ICC was excluded from this analysis), simultaneously adjusted for age, gender, and HIV-exposure category, for the four time periods: р1989; 1990-1992, 1993-1994, and 1995-1996 . Compared to the observed frequencies, some changes were noted. The downward TRENDS OF AIDS-DEFINING DISEASES 977 Tables) , the upward trend for mycobacterioses was less marked (from 2.4% to 5.6%); the upward trend for brain toxoplasmosis was more evident (from 6.1% to 11.4%); and the trend of decrease for KS was less marked (from 7.6% to 5.9%) as was that for NHL (from 5.2% to 3.7%). According to level of CD4 + cell counts, the frequencies of mycobacterioses, bacterial infections, KS and NHL were higher at high (i.e. у100 cells/mm 3 ) CD4 + counts, whereas those of PCP and viral infections were higher at lower (i.e. р49 cells/ mm 3 ) CD4 + counts (Table 4 ). The remaining groups of AIDSdefining diseases did not substantially vary by CD4 + cell count, and the temporal trends of the 11 groups of AIDS-defining diseases were similar within strata of CD4 + cell counts (Table 4) . 
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Discussion
The results of this study constitute comprehensive data on all AIDS-defining diseases before the large-scale introduction of HIV protease inhibitors, which began in Italy in August 1996. Although the temporal patterns observed in the frequency of AIDS-defining diseases at univariate analysis were substantially confirmed by the multivariate analysis, we noted an extenuation of the downward trend for KS and mycoses, and of the upward trend for protozoal infections and brain toxoplasmosis. The addition of new diseases to the case definition always reduces the probability that a disease originally in the case definition will be the AIDS-defining disease, particularly when the new disease tends to occur in the earlier stages of immunosuppression. Accordingly, we took into consideration the potential effect of changes in case definition by including only the AIDS-defining diseases that constituted the pre-1987 AIDS definition. The results of this analysis showed that the spectrum of AIDS-defining diseases remained more homogeneous during the study period. In particular, the marked upward trend observed for mycobacterioses could be quite completely explained by the introduction of pulmonary tuberculosis in the case definition in 1993. 9 As shown in other studies, 23 the decreasing trend in the CD4 + cell count observed among Italian AIDS cases 1 appeared to influence the temporal spectrum of AIDS-defining diseases. We showed that PCP emerges at low level of CD4 + cell counts, and therefore the decline of CD4 + cells at AIDS diagnosis partially explained the less marked decline of PCP compared to what was expected on the basis of the introduction of prophylactic treatments.
A decreasing trend of PCP as AIDS-defining disease has been reported in different countries, 12, 17, 24 and this pattern was largely attributed to PCP primary prophylaxis. In Italy, PCP declined more recently, but it remained the most frequent clinical manifestation of AIDS after mycoses. A cross-sectional investigation, conducted in Italy among those diagnosed with AIDS in the first quarter of 1995, showed that only 39.1% of TRENDS OF AIDS-DEFINING DISEASES 979 Group of defining CD4 у100 CD4 50-99 CD4 р49
conditions 1990-1992 1993-1994 1995-1996 1990-1992 1993-1994 1995-1996 1990-1992 1993-1994 1995-1996 them received PCP prophylaxis before AIDS diagnosis. 25 According to similar studies conducted in the UK 12 and the US, 26 in Italy also HIV-infected individuals who became aware of being HIV-positive shortly before AIDS diagnosis were less likely to have started PCP prophylaxis. 25 Thus, in contrast with the undoubted benefits of PCP prophylaxis, 27 its spread among HIVinfected individuals in Italy is still limited, and interventions aimed at increasing counselling and testing for individuals at risk for HIV infection and AIDS are needed. Primary prophylaxis for PCP may shift the clinical manifestation of HIV infection from PCP to other illnesses that emerge at lower levels of immunosuppression, with the potential exception of toxoplasmosis. [28] [29] [30] The decrease in the frequency of mycoses observed in this study may be also due, in addition to factors previously described (i.e. decreasing percentage of IDU among Italian cases, decreasing CD4 + cell counts at AIDS diagnosis, changes of case definition), to the introduction of antifungal agents like fluconazole, as already reported. 17, 31 Trends in the frequency of opportunistic infections other than mycoses and PCP showed different patterns. The increase in viral infections seemed to be partly attributable to changes in case definition, since it was less apparent when the analysis was restricted to the conditions included in the pre-1987 definition. Noteworthy increases were seen for mycobacterioses and bacterial infections (particularly between 1992 and 1996, when the frequency of such infections doubled), and protozoal infections. Overall, this picture seems to confirm the evidence coming from a cohort analysis of men with AIDS who received PCP prophylaxis. 27 Among them, mycobacterioses, CMV diseases, oesophageal candidiasis and wasting syndrome were more frequent among those who received PCP prophylaxis.
As concerns trends of AIDS-defining cancers, the results of this study confirm the well-described decline of KS in Europe and the US. 11 Changes of case definition and the decline in the number of CD4 + cells at AIDS diagnosis are likely to explain at least part of this decline.
The design of this study did not allow the evaluation of other factors that may have influenced temporal trends of the clinical manifestation of AIDS. The AIDS Registry data only reflect morbidity at the time of AIDS diagnosis, and thus they do not encompass the complete spectrum of HIV-related morbidity. Since information on prophylactic and anti-retroviral treatments was not routinely collected, we could not directly rule out the effect of the large-scale introduction of such treatments. Moreover, no information was available on the time at which individuals were infected, and we could not evaluate whether the AIDS-defining diseases have different incubation periods. In Italy, the highest incidence of HIV infection was estimated in the late 1980s 32 thus the spectrum of AIDS-defining diseases herein observed represented in particular AIDS cases with an incubation period of less than 10 years. CD4 + cell counts at AIDS diagnosis have been routinely collected only since 1990, thus we were not able to evaluate the effect of the changing pattern of immunosuppression for the entire study period. Finally, we could not evaluate the possibility that variations in diagnostic standards have occurred over time.
The main findings of this study can be summarized as follows. The frequency of PCP during the 1990s steadily declined overall and within strata of CD4 + cells, suggesting that the decline was due to primary prophylaxis. However, PCP is still the second most common AIDS-defining disease. The decline of mycoses, KS and NHL may be partially attributable to changes in the case definition and to the decline in CD4 + cell counts at AIDS diagnosis. In contrast to these declines, other opportunistic infections increased over time, eliciting discussion on the best strategy to adopt to prevent as many opportunistic infections as possible.
In the future, this analysis will provide a reference tool to evaluate the impact of the new therapeutic strategies. It will be useful to follow individuals with long incubation periods before initial AIDS clinical manifestations. Such treatments are potentially able to produce real and sustained benefits for those with HIV infection, and are likely to affect the spectrum of AIDS-defining diseases. 33 
